MedTrace Logo

Evaluation of Immediate v. Delayed CT/NG Test for Treatment in the ED

NCT01989130 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2019-08-13

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if immediate availability of GeneXpert® CT/NG test results reduces the overtreatment rate for ED patients with suspected gonorrhea or chlamydia and to assess changes in clinician management decisions with real-time test results.

Conditions

  • Reproductive Tract Infections

Interventions

DEVICE

Roche AMPLICOR CT/NG

DEVICE

Cepheid Xpert CT/NG Test

Sponsors & Collaborators

  • Cepheid

    collaborator INDUSTRY

  • George Washington University

    lead OTHER

Principal Investigators

  • Larissa May, MD · George Washington University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01989130 on ClinicalTrials.gov